CRO Concept Stocks Rally in Early Trading; Sino Biological Up 14.23%
CRO concept stocks rallied in early trading on August 10, with Sino Biological surging 14.23% and GemPharmatech advancing 11.98%. Bide Pharmatech rose 10.71%, while Hongbo Pharma, Baihua Pharma and Aopumai each gained more than 7%. Trading volumes expanded across the sector, with Asymchem and Baichen Pharma also moving higher. Market attention centred on the pharmaceutical research and development outsourcing segment.
On the morning of August 10, CRO concept stocks rallied collectively in early trading, with multiple names posting significant gains. Sino Biological rose 14.23% and GemPharmatech advanced 11.98%, while Hongbo Pharma, Baihua Pharma and Aopumai each gained more than 7%. Bide Pharmatech also recorded a notable rise, although its exact gain was not uniformly confirmed. During early trading, the CRO sector traded actively with expanded volumes on related stocks. In addition to the names above, Asymchem and Baichen Pharma also moved higher in tandem, with market attention concentrated on the pharmaceutical research and development outsourcing segment.